Trade BB Biotech AG - BION CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.35 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.011528% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.010695% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | CHF | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Switzerland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 30.5 |
| Open | 30.45 |
| 1-Year Change | -33% |
| Day's Range | 29.95 - 30.55 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 30.50 | -0.15 | -0.49% | 30.65 | 30.75 | 29.65 |
| Mar 28, 2025 | 31.35 | -0.25 | -0.79% | 31.60 | 31.60 | 30.65 |
| Mar 27, 2025 | 31.55 | -0.05 | -0.16% | 31.60 | 31.75 | 30.85 |
| Mar 26, 2025 | 31.50 | -0.45 | -1.41% | 31.95 | 32.25 | 31.50 |
| Mar 25, 2025 | 32.20 | -0.15 | -0.46% | 32.35 | 32.50 | 31.80 |
| Mar 24, 2025 | 32.30 | 0.60 | 1.89% | 31.70 | 32.35 | 31.65 |
| Mar 21, 2025 | 31.35 | -1.55 | -4.71% | 32.90 | 33.00 | 30.55 |
| Mar 20, 2025 | 34.60 | -0.05 | -0.14% | 34.65 | 34.95 | 34.60 |
| Mar 19, 2025 | 34.85 | 0.00 | 0.00% | 34.85 | 35.00 | 34.35 |
| Mar 18, 2025 | 35.00 | -0.05 | -0.14% | 35.05 | 35.45 | 34.45 |
| Mar 17, 2025 | 34.70 | -0.20 | -0.57% | 34.90 | 35.25 | 34.55 |
| Mar 14, 2025 | 34.60 | -0.10 | -0.29% | 34.70 | 35.25 | 34.30 |
| Mar 13, 2025 | 34.65 | -0.30 | -0.86% | 34.95 | 35.05 | 34.35 |
| Mar 12, 2025 | 35.20 | 0.60 | 1.73% | 34.60 | 35.30 | 34.40 |
| Mar 11, 2025 | 34.45 | -0.75 | -2.13% | 35.20 | 35.30 | 34.05 |
| Mar 10, 2025 | 35.20 | -0.75 | -2.09% | 35.95 | 36.30 | 35.10 |
| Mar 7, 2025 | 36.25 | 0.30 | 0.83% | 35.95 | 36.25 | 35.95 |
| Mar 6, 2025 | 36.25 | 0.00 | 0.00% | 36.25 | 36.50 | 35.75 |
| Mar 5, 2025 | 36.20 | -0.10 | -0.28% | 36.30 | 36.70 | 36.10 |
| Mar 4, 2025 | 35.75 | -0.60 | -1.65% | 36.35 | 36.55 | 35.75 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
BB Biotech Company profile
About BB BIOTECH AG
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, BB BIOTECH AG revenues decreased from SF741.8M to -SF343.6M. Net loss totaled SF404.8M vs. income of SF691.2M. Revenues reflect Unrealized Gains/Losses on Securities decrease from SF460.9M to -SF652.2M, Dividend Income decrease from SF243K to SF0K, Other income decrease of 83% to SF4K. Net loss reflects Management fees increase of 27% to SF50.7M (expense).
Equity composition
3/2016, 5-for-1 stock split (Factor: 5).
| Industry: | Biotechnology & Medical Research (NEC) |
Schwertstrasse 6
SCHAFFHAUSEN
SCHAFFHAUSEN 8200
CH
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com